Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and side-effect-free drug production.
Chirality Biosciences has raised $3.1M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Chirality Biosciences's investors include Pioneer Fund.
Chirality Biosciences is headquartered in Farmingdale, United States.
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and side-effect-free drug production.
Chirality Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Chirality Biosciences — Funding & Investors." VCBacked, October 27, 2025, https://www.vcbacked.co/company/chirality-biosciences. Accessed September 16, 2026.
VCBacked. (2025). Chirality Biosciences — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/chirality-biosciences
{{cite web |title=Chirality Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/chirality-biosciences |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated